These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37999596)

  • 1. Depicting the Profile of METTL3-Mediated lncRNA m6A Modification Variants and Identified SNHG7 as a Prognostic Indicator of MNNG-Induced Gastric Cancer.
    Liu T; Feng Y; Yang S; Ge Y; Zhang T; Li J; Li C; Ruan Y; Luo B; Liang G
    Toxics; 2023 Nov; 11(11):. PubMed ID: 37999596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. METTL3-Regulated lncRNA SNHG7 Drives MNNG-Induced Epithelial-Mesenchymal Transition in Gastric Precancerous Lesions.
    Jian J; Feng Y; Wang R; Li C; Zhang L; Ruan Y; Luo B; Liang G; Liu T
    Toxics; 2024 Aug; 12(8):. PubMed ID: 39195675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term MNNG exposure promotes gastric carcinogenesis by activating METTL3/m6A/miR1184 axis-mediated epithelial-mesenchymal transition.
    Liu T; Feng YL; Wang RY; Yang S; Ge YL; Zhang TY; Li J; Li CY; Ruan Y; Luo B; Liang GY
    Sci Total Environ; 2024 Feb; 913():169752. PubMed ID: 38163601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential role of N6-methyladenosine modification of LncRNAs in contributing to the pathogenesis of chronic glomerulonephritis.
    Liu T; Zhuang XX; Qin XJ; Wei LB; Gao JR
    Inflamm Res; 2023 Mar; 72(3):623-638. PubMed ID: 36700958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative proteomics and m6A microarray analyses of the signatures induced by METTL3 reveals prognostically significant in gastric cancer by affecting cellular metabolism.
    Peng G; Chen S; Zheng N; Tang Y; Su X; Wang J; Dong R; Wu D; Hu M; Zhao Y; Liu M; Wu H
    Front Oncol; 2022; 12():996329. PubMed ID: 36465351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer.
    Liu T; Yang S; Sui J; Xu SY; Cheng YP; Shen B; Zhang Y; Zhang XM; Yin LH; Pu YP; Liang GY
    J Cell Physiol; 2020 Jan; 235(1):548-562. PubMed ID: 31232471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and comparison of m6A modifications in glioblastoma non-coding RNAs with MeRIP-seq and Nanopore dRNA-seq.
    Krusnauskas R; Stakaitis R; Steponaitis G; Almstrup K; Vaitkiene P
    Epigenetics; 2023 Dec; 18(1):2163365. PubMed ID: 36597408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N6-methyladenosine Modification-Related Long Non-Coding RNAs are Potential Biomarkers for Predicting the Prognosis of Patients With Osteosarcoma.
    Yang K; Wang F; Li K; Peng G; Yang H; Xu H; Xiang Y; Sun H
    Technol Cancer Res Treat; 2022; 21():15330338221085354. PubMed ID: 35422168
    [No Abstract]   [Full Text] [Related]  

  • 9. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.
    Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. METTL3-Mediated lncRNA m
    Song Y; Pan Y; Wu M; Sun W; Luo L; Zhao Z; Liu J
    Stem Cell Rev Rep; 2021 Dec; 17(6):2276-2290. PubMed ID: 34505967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Joint analysis of lncRNA m
    Lv Z; Sun L; Xu Q; Xing C; Yuan Y
    Cancer Cell Int; 2020; 20():464. PubMed ID: 32982586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and Validation of METTL3-Related Molecules for Predicting Prognosis and Efficacy of Immunotherapy in Gastric Cancer Based on m6A Methylome and Transcriptome Sequencing Analysis.
    Chen S; Su X; Wang J; Zheng N; Tang Y; Peng G; Dong R; Lu F; Liu M; Zhao Y; Wu H
    Front Oncol; 2022; 12():935239. PubMed ID: 35965524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of long non-coding RNA expression profiles of GC-1spg cells with m6A methylation knockdown.
    Zhong D; Yao C; Zhang L; Wang J; Liu Q; Shi D; Jiang M; Li H
    Gene; 2023 Jun; 871():147430. PubMed ID: 37062454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N6-methyladenosine methylation mediates non-coding RNAs modification in microplastic-induced cardiac injury.
    Zhang M; Shi J; Zhou J; Song L; Ding J; Deng HP; Weng L; Zhu Y; Xu Z
    Ecotoxicol Environ Saf; 2023 Jun; 262():115174. PubMed ID: 37354568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic N6-methyladenosine modification of lncRNA modulated by METTL3 during bacterial disease development in an echinoderm.
    Zhang S; Shao Y; Li D; Li C
    Fish Shellfish Immunol; 2022 May; 124():497-504. PubMed ID: 35483599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of m6A modified circ0049271 induced by MNNG in precancerous lesions of gastric cancer.
    Zhang Y; Chen Z; Song J; Qian H; Wang Y; Liang Z
    Heliyon; 2024 Aug; 10(16):e35654. PubMed ID: 39224358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. METTL3-Mediated LncRNA
    Yang J; Yang Q; Huang X; Yan Z; Wang P; Gao X; Li J; Gun S
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing m
    Huang Y; Lv Y; Yang B; Zhang S; Bixia Liu ; Zhang C; Hu W; Jiang L; Chen C; Ji D; Xiong C; Liang Y; Liu M; Ying X; Ji W
    Heliyon; 2024 Apr; 10(7):e28165. PubMed ID: 38560117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. m6A-related bioinformatics analysis and functional characterization reveals that METTL3-mediated NPC1L1 mRNA hypermethylation facilitates progression of atherosclerosis via inactivation of the MAPK pathway.
    Zhang G; Li X; Huang X
    Inflamm Res; 2023 Mar; 72(3):429-442. PubMed ID: 36583755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The m6A methylation profiles of immune cells in type 1 diabetes mellitus.
    Wang Y; Xu L; Luo S; Sun X; Li J; Pang H; Zhou J; Zhou Y; Shi X; Li X; Huang G; Xie Z; Zhou Z
    Front Immunol; 2022; 13():1030728. PubMed ID: 36457997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.